Please Note - Streaming News is only available to subscribers to the Active Level and above
RNS News Service
I confirm that I am accessing this story in my capacity as a private investor and NOT for professional purposes.
Form 38.5(b) - Willis Towers Watson PLC
RNS
RNS Number : 6433D
Goldman Sachs & Co. LLC
29 October 2020
FORM 38.5(b)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNISED INTERMEDIARY STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY
1. KEY INFORMATION
Name of exempt principal trader
GOLDMAN SACHS & CO. LLC
Company dealt in
WILLIS TOWERS WATSON PLC
Class of relevant security to which the dealings being disclosed relate (Note1)
USD 0.000304635 ordinary shares
Date of dealing
28 October 2020
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 2)
Long
Short
Number
(%)
Number
(%)
(1) Relevant securities
520,425.542
(0.40)
308,480.542
(0.23)
(2) Derivatives (other than options)
51,219
(0.03)
373,212
(0.28)
(3) Options and agreements to purchase/sell
0
(0.00)
0
(0.00)
Total
571,644.542
(0.44)
681,692.542
(0.52)
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 2)
Class of relevant security:
Long
Short
Number
(%)
Number
(%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
3. DEALINGS (Note 3)
(a) Purchases and sales
Purchase/sale
Number of relevant securities
Price per unit (Note 4)
Purchase
22
193.5500 USD
Purchase
42
193.9100 USD
Purchase
74
193.9100 USD
Sale
100
193.0100 USD
Sale
25
193.2200 USD
Sale
2
193.2200 USD
Sale
100
193.3600 USD
Sale
25
193.5900 USD
Sale
25
193.5900 USD
Sale
51
193.5950 USD
Sale
100
193.6100 USD
Sale
100
193.6150 USD
Sale
25
193.6300 USD
Sale
100
193.6750 USD
Sale
50
193.6750 USD
Sale
26
193.6900 USD
Sale
25
193.6950 USD
Sale
100
193.7500 USD
Sale
50
193.7500 USD
Sale
25
193.7650 USD
Sale
6
193.8000 USD
Sale
100
193.8000 USD
Sale
25
193.8000 USD
Sale
100
193.8300 USD
Sale
50
193.8400 USD
Sale
25
193.8550 USD
Sale
100
193.8550 USD
Sale
25
193.9000 USD
Sale
50
193.9100 USD
Sale
5,313
193.9100 USD
Sale
18
193.9100 USD
Sale
20
193.9100 USD
Sale
82
193.9100 USD
Sale
50
193.9100 USD
Sale
113
193.9100 USD
Sale
1,119
193.9100 USD
Sale
1,037
193.9100 USD
Sale
50
193.9100 USD
Sale
6,991
193.9100 USD
Sale
25
193.9250 USD
Sale
25
193.9300 USD
Sale
25
193.9300 USD
Sale
100
193.9600 USD
Sale
100
193.9800 USD
Sale
25
193.9900 USD
Sale
25
194.0050 USD
Sale
40
194.0300 USD
Sale
60
194.0300 USD
Sale
100
194.0300 USD
Sale
25
194.0350 USD
Sale
75
194.0400 USD
Sale
25
194.0400 USD
Sale
50
194.0500 USD
Sale
25
194.0650 USD
Sale
100
194.0800 USD
Sale
100
194.0900 USD
Sale
50
194.1000 USD
Sale
26
194.1500 USD
Sale
100
194.1550 USD
Sale
25
194.1800 USD
Sale
7
194.1800 USD
Sale
100
194.2000 USD
Sale
15
194.2300 USD
Sale
100
194.2750 USD
Sale
25
194.2800 USD
Sale
25
194.3000 USD
Sale
100
194.3600 USD
Sale
100
194.4200 USD
Sale
25
194.4300 USD
Sale
25
194.4450 USD
Sale
25
194.5550 USD
Sale
25
194.6200 USD
Sale
100
194.6600 USD
Sale
75
194.6700 USD
Sale
22
194.6700 USD
Sale
3
194.6700 USD
Sale
26
194.6750 USD
Sale
100
194.6800 USD
Sale
100
194.6800 USD
Sale
2
194.6900 USD
Sale
20
194.6900 USD
Sale
25
194.7000 USD
Sale
100
194.7000 USD
Sale
25
194.7000 USD
Sale
52
194.7200 USD
Sale
48
194.7200 USD
Sale
100
194.7250 USD
Sale
50
194.7300 USD
Sale
100
194.7450 USD
Sale
100
194.7550 USD
Sale
25
194.7550 USD
Sale
25
194.7975 USD
Sale
100
194.8400 USD
Sale
50
194.8700 USD
Sale
25
195.0850 USD
Sale
100
195.1750 USD
Sale
100
195.2100 USD
Sale
22
195.2200 USD
Sale
3
195.2200 USD
Sale
25
195.2400 USD
Sale
100
195.2550 USD
Sale
100
195.3000 USD
Sale
100
195.3050 USD
Sale
25
195.3250 USD
Sale
100
195.3450 USD
Sale
25
195.3900 USD
Sale
100
195.4100 USD
Sale
25
195.4100 USD
Sale
100
195.4300 USD
Sale
100
195.4450 USD
Sale
26
195.4600 USD
Sale
25
195.4700 USD
Sale
100
195.4800 USD
Sale
25
195.4950 USD
Sale
25
195.5000 USD
Sale
25
195.5000 USD
Sale
26
195.5100 USD
Sale
100
195.5150 USD
Sale
75
195.5300 USD
Sale
100
195.5350 USD
Sale
100
195.5500 USD
Sale
100
195.5500 USD
Sale
26
195.5700 USD
Sale
100
195.6000 USD
Sale
25
195.6100 USD
Sale
50
195.6100 USD
Sale
75
195.6300 USD
Sale
14
195.6400 USD
Sale
11
195.6400 USD
Sale
25
195.6800 USD
Sale
25
195.6950 USD
Sale
3
195.7300 USD
Sale
97
195.7300 USD
Sale
100
195.7700 USD
Sale
26
195.7700 USD
Sale
51
195.7900 USD
Sale
100
195.8000 USD
Sale
50
195.8000 USD
Sale
25
195.8200 USD
Sale
100
195.8550 USD
Sale
25
195.8550 USD
Sale
100
195.8550 USD
Sale
25
195.8700 USD
Sale
50
195.9500 USD
Sale
90
196.0000 USD
Sale
100
196.0000 USD
Sale
10
196.0000 USD
Sale
100
196.0600 USD
Sale
100
196.1200 USD
Sale
51
196.2000 USD
Sale
15
196.2200 USD
Sale
27
196.2900 USD
Sale
16
196.2900 USD
Sale
54
196.2900 USD
Sale
3
196.2900 USD
Sale
1
196.4500 USD
Sale
25
196.5300 USD
Sale
74
196.5300 USD
Sale
100
196.6650 USD
Sale
25
196.6700 USD
Sale
25
196.7250 USD
Purchase (Loan Partial Return)
548
N/A
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD
Nature of transaction (Note 5)
Number of relevant securities (Note 6)
Price per unit (Note 4)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name,e.g. call option
Writing, selling, purchasing, varying etc.
Number of securities to which the option relates (Note 7)
Exercise price
Type, e.g. American, European etc.
Expiry date
Option money paid/received per unit (Note 4)
(ii) Exercising
Product name,e.g. call option
Number of securities
Exercise price per unit (Note 4)
(d) Other dealings (including transactions in respect of new securities) (Note 3)
Nature of transaction (Note 7)
Details
Price per unit (if applicable) (Note 4)
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
NONE
Is a Supplemental Form 8 attached? (Note 9) YES
Date of disclosure
29 October 2020
Contact name
Kashif Rafiq and Papa Lette
Telephone number
+44(20) 7051 0547 / +44(20) 7774 7442
Name of offeree/offeror with which connected
WILLIS TOWERS WATSON PLC
Nature of connection (Note 9)
Advisor to Offeree
SUPPLEMENTAL FORM 38.5(b)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
OPEN POSITIONS (Note 1)
Product name,e.g. call option
Written or purchased
Number of relevant securities to which the option or derivative relates
Exercise price (Note 2)
Type, e.g. American, European etc.
Expiry date
Swap
Sold
185
0.0000
N/A
23/09/2021
Swap
Sold
273
0.0000
N/A
04/01/2021
Swap
Sold
43,330
0.0000
N/A
14/04/2021
Swap
Sold
69,482
0.0000
N/A
14/04/2021
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rules 8 and 38.5 of the Rules. If in doubt, consult the Panel.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.